Form 4: Neuronetics Executive Awarded Performance-Based Stock Units

William Andrew Macan, an executive at Neuronetics, Inc., was granted 135,000 performance-based restricted stock units (PRSUs) that vest upon achieving specific cash flow breakeven targets.

Summary

• William Andrew Macan, an EVP, GC, CCO and CS at Neuronetics, Inc., received 135,000 performance restricted stock units (PRSUs) on December 10, 2024.
• These PRSUs will vest on December 31, 2025, contingent upon Neuronetics achieving cash flow breakeven for specific fiscal quarters.
• 25% of the award vests if cash flow breakeven is achieved for the quarter ending June 30, 2025.
• An additional 50% vests if cash flow breakeven is achieved for the quarter ending September 30, 2025.
• The final 25% vests if cash flow breakeven is achieved for the quarter ending December 31, 2025.
• Each PRSU represents the right to receive one share of Neuronetics common stock.

Sentiment

Score: 7

Explanation: The document reflects a positive incentive structure for management, aligning their interests with company performance. The sentiment is neutral to positive as it is a standard practice.

Positives

• The performance-based nature of the stock units aligns executive compensation with the company's financial goals.
• The vesting schedule encourages sustained performance through the end of 2025.
• The award provides a clear incentive for the executive to drive the company towards cash flow breakeven.

Risks

• The vesting of the stock units is contingent on the company achieving cash flow breakeven, which may not be guaranteed.
• Failure to meet the cash flow breakeven targets will result in the executive not receiving the full award.

Future Outlook

The vesting of the stock units is tied to the company achieving cash flow breakeven in specific future quarters, indicating a focus on financial performance.

Industry Context

Performance-based stock awards are a common practice in the industry to align executive interests with company performance and shareholder value.

Comparison to Industry Standards

• Many companies in the medical device and technology sectors use performance-based equity awards to incentivize executives.
• The specific cash flow breakeven targets are unique to Neuronetics, but the structure of the award is consistent with industry norms.
• Companies like InMode and Shockwave Medical also use similar performance-based compensation structures.

Stakeholder Impact

• Shareholders may view the performance-based stock units positively, as they align executive compensation with company performance.
• Employees may see this as a positive sign of the company's commitment to growth and financial stability.

Key Dates

Keywords

performance restricted stock units, PRSU, stock award, executive compensation, cash flow breakeven, Neuronetics, STIM